How do I find out if I qualify for a metastatic breast cancer study in Connecticut?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in Connecticut to take part?

Not necessarily. These studies have a site in Connecticut, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a metastatic breast cancer trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · Connecticut

Metastatic Breast Cancer clinical trials in Connecticut

We’re tracking 76 recruiting metastatic breast cancer studies with a site in Connecticut — including Phase 1, Phase 2 and Phase 3 studies, each written for real people, not researchers.

Recruiting studies in Connecticut

NCT04181060RecruitingPhase 3
Osimertinib alone or with bevacizumab for EGFR-mutant lung cancer
This Phase 3 trial tests whether starting osimertinib with or without bevacizumab helps people with advanced EGFR-mutant lung cancer live longer and control the cancer better. Your EGFR mutation test result and past treatments are key to whether you can join.
Derby, ConnecticutAges 18 years+
NCT07042295RecruitingPhase 2
Amivantamab or Cetuximab for Skin Cancer in People with Weakened Immune Systems
This trial tests two drugs, amivantamab with hyaluronidase or cetuximab, in people with weakened immune systems who have advanced skin cancer (squamous cell carcinoma). The goal is to see if these treatments can help shrink or control the cancer.
New Haven, ConnecticutAges 18 years+
NCT07194044RecruitingPhase 1
Testing a treatment schedule for metastatic Ewing sarcoma
This trial tests a new schedule of standard chemotherapy drugs to see if it improves outcomes for people with metastatic Ewing sarcoma or CIC-rearranged sarcoma. It is for patients who have not had prior cancer treatment, except possibly one initial cycle of VDC.
Hartford, ConnecticutAges 1 year+
NCT06422806RecruitingPhase 3
Immunotherapy plus chemo for aggressive sarcoma
This trial compares a combination of immunotherapy (pembrolizumab) plus chemotherapy (doxorubicin) versus chemotherapy alone for people with aggressive, poorly differentiated sarcomas that have spread or cannot be removed. The goal is to see if adding immunotherapy helps shrink tumors or slow their growth better than chemotherapy alone.
Derby, ConnecticutAges 18 years+

Metastatic Breast Cancer trials by city in Connecticut

Hartford

Where these studies are running in Connecticut

Institutions with a site for the recruiting metastatic breast cancer studies listed above.

Smilow Cancer Hospital Care Center - Waterford · 3 studies
Smilow Cancer Hospital Care Center-Trumbull · 3 studies
Yale University · 3 studies
Smilow Cancer Hospital Care Center - Guilford · 2 studies
Smilow Cancer Hospital Care Center at Greenwich · 2 studies
Smilow Cancer Hospital Care Center at Long Ridge · 2 studies
Smilow Cancer Hospital Care Center-Fairfield · 2 studies
Smilow Cancer Hospital-Derby Care Center · 2 studies

What taking part in a metastatic breast cancer study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Metastatic Breast Cancer trials in other states

Common questions

Are there metastatic breast cancer clinical trials in Connecticut?: Yes. We're currently tracking 76 recruiting metastatic breast cancer studies with a site in Connecticut, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a metastatic breast cancer study in Connecticut?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in Connecticut to take part?: Not necessarily. These studies have a site in Connecticut, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a metastatic breast cancer trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New metastatic breast cancer studies open in Connecticut regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.